Alpha-Tryptase Linked to Prevalence of Anaphylaxis, Food Allergy
FRIDAY, Sept. 29, 2023 (HealthDay News) — Alpha-tryptase is associated with increased prevalence of anaphylaxis or severe reaction to food, according to a study published online Aug. 6 in the Journal of Allergy and Clinical Immunology.Abigail Lang, M…
Learn MoreLa FDA solicita más datos sobre el primer antídoto sin agujas para reacciones alérgicas graves
JUEVES, 21 de septiembre de 2023 (HealthDay News) — En una movida sorprendente, la Administración de Alimentos y Medicamentos de EE.UU. (FDA, por sus siglas en inglés) ha decidido no aprobar una alternativa sin aguja al EpiPen para el tratamiento de …
Learn MoreFDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.Approval of the Neffy (epin…
Learn MoreFDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.Approval of the Neffy…
Learn MoreThe Most Common Symptoms for Seasonal Allergies, Food Allergies & More
MONDAY, May 22, 2023 (HealthDay News) — Maybe you can’t weed your garden without sneezing. Perhaps your eyes start watering when you clean your home. Did your skin begin itching last night during dinner?You may have an allergy, but you’re not alone. …
Learn MoreEmergency Anaphylaxis Observation Times Can Be Cut for Children
MONDAY, May 22, 2023 (HealthDay News) — Most children seen in the emergency department for anaphylaxis can be discharged after two hours or less, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from Apr…
Learn MoreUn panel de la FDA recomienda la aprobación del primer aerosol nasal contra los ataques graves de alergia
VIERNES, 12 de mayo de 2023 (HealthDay News) — Unos asesores externos de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. votaron el jueves a favor de la aprobación de Neffy, el primer aerosol nasal de epinefrina para las reacciones alé…
Learn MoreFDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergic Reactions
FRIDAY, May 12, 2023 (HealthDay News) — Outside advisers for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.Although most of the Pulmonary-Allergy D…
Learn MoreFDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks
FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.Although most of the Pulmonary-Allergy D…
Learn MoreLatex Allergy: What It Is, Causes, Symptoms & Treatments
TUESDAY, May 9, 2023 (HealthDay News) — Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.Latex allergy can trigger a rang…
Learn More